Emily Gilbert

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 236 citations · Full text

Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Zara Izadi, Erica J. Brenner, Satveer K. Mahil et al. · JAMA Network Open · 2021 · 114 citations · Full text

Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance

Manuel F. Ugarte‐Gil, Graciela S. Alarcón, Zara Izadi et al. · Annals of the Rheumatic Diseases · 2022 · 88 citations · Full text

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Sebastian E. Sattui, Richard Conway, Michael Putman et al. · The Lancet Rheumatology · 2021 · 48 citations · Full text

Rheumatology, Retrospective Cohort Study, Vasculitis +11

Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study

Gabriel Figueroa‐Parra, Emily Gilbert, Maria O Valenzuela-Almada et al. · The Lancet Rheumatology · 2022 · 44 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +12